Life can be A LOT like driving on an interstate highway. It’s important to stay in your lane, only glance backwards if you’re planning to make a change…and always watch out for David Beckham because he might swerve bend that corner woah! So, when it was officially announced in September 2021 that Prenetics (NASDAQ: PRE), a diagnostic and genetic testing company based in Hong Kong, was going public through a SPAC merger…I fully admit not even spending one iota of energy on the financial news headline. But I initially crossed paths with Prenetics last March when the company reached out to me regarding an upcoming strategic realignment that would focus on the U.S. consumer health market. And while I didn’t sign an NDA…I’ll keep the full extent of what I wrongfully assumed would be brief friendly surface-level introduction conversation confidential. Though, two major focuses of my strategic commentary did turn into public knowledge…David Beckham becoming a strategic investor of Prenetics (and co-founding a supplement brand called IM8 Health) and the acquisition of Europa Sports Partners. So, with more cash on the balance sheet (from selling a share of its Insighta joint venture to Tencent) and leadership recently confirming that going forward Prenetics would concentrate fully on the consumer health businesses it wholly owns and are scaling aggressively…my latest first principles thinking content will equally focus in-depth on the Europa Sports Partners and IM8 Health deal activity.